Last week, President Donald Trump warned of Iranian sleeper cells operating in the United States. "We know where most of them ...
Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially ...
Researchers show that pharmacological activation of hypoxia signaling improves metabolism, limits fat accumulation, and ...
ImmunityBio, Inc. remains a Buy, with Anktiva’s regulatory and global expansion driving the investment thesis. Learn more ...
Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with ...
RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...
Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells ...
For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...
The approach relies on a specially engineered scaffold that links three naturally occurring cytokines known to promote immune memory.
A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results